IMDX Stock Summary and Trading Ideas (Insight Molecular Diagnostics | NASDAQ:IMDX)

Insight Molecular Diagnostics Inc is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. The Company's flagship technology quantifies a molecular biomarker known as donor-derived cell-free DNA (dd-cfDNA). It is also in the process of rebranding its RUO test kit, GraftAssure, as GraftAssureIQ, and rebranding its future in-vitro diagnostic (IVD) test kit as GraftAssureDx.

What symbol and exchange does Insight Molecular Diagnostics shares trade?

Insight Molecular Diagnostics trades on the NASDAQ stock market under the symbol IMDX.

What is Insight Molecular Diagnostics stock price doing today?

As of April 2, 2026, IMDX stock price climbed to $3.76 with 292,618 million shares trading.

What is Insight Molecular Diagnostics's Beta?

IMDX has a beta of 2.21, meaning it tends to be more sensitive to market movements. IMDX has a correlation of 0.07 to the broad based SPY ETF.

How much is Insight Molecular Diagnostics worth?

IMDX has a market cap of $120.95 million. This is considered a Micro Cap stock.

How much money does Insight Molecular Diagnostics make?

Last quarter Insight Molecular Diagnostics reported $1 million in Revenue and -$.27 earnings per share. This beat revenue expectation by $854,000 and missed earnings estimates by -$.03.

What are the top ETFs holding Insight Molecular Diagnostics?

The top ETF exchange traded funds that IMDX belongs to (by Net Assets): VTI, VXF, IWC.

What are the support and resistance levels for Insight Molecular Diagnostics (IMDX)?

IMDX support price is $3.09 and resistance is $3.79 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that IMDX shares will trade within this expected range on the day.